The whole NOAK advertising scheme seems like a huge win for the pharma companies to me. (Possibly also for the patients. Not so much for the affordability of our medical system.)
The whole NOAK advertising scheme seems like a huge win for the pharma companies to me. (Possibly also for the patients. Not so much for the affordability of our medical system.)
Of course, novel reversal agents are coming and each one will likely only reverse one drug... and each one will cost an arm and a leg.
I understand why patients do it. I just don't like bleeding that I often can't directly control.
Can't that be done digitally now?
http://www.thenorthernecho.co.uk/news/14030069.Warfarin_scre...
https://twitter.com/CDDFTNHS/status/666205891629359104
https://twitter.com/NHSIQ/status/666240577877499905
EDIT: Also http://www.nice.org.uk/guidance/ta249
(Not even getting into the topics of "how much is not having to do that every 2 weeks worth" and "can't the patient pay the difference if they want to?")
(In the US, a 15-minute doctor's visit could easily cost an end-patient $150-$200 out of pocket if their insurance doesn't cover it or has a high deductible; doing a blood draw every two weeks can get very expensive at that rate.)
This doesn't make much sense as an American.